LSTA Q1 2017 Earnings — Lisata Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

LSTALisata Therapeutics, Inc.

$44M

Q1 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$8M+5.8% YoY

Gross Profit

-$120,000-1.5% margin

Operating Income

-$6M-81.2% margin

Net Income

-$9M-118.1% margin

EPS (Diluted)

$-16.74

QoQ Revenue Growth

-22.1%

Cash Flow

Operating Cash Flow

-$10M

Free Cash Flow

-$10M

Stock-Based Comp.

$533,198

Balance Sheet

Total Assets

$49M

Total Liabilities

$51M

Stockholders' Equity

-$790,974

Cash & Equivalents

$12M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$8M	$7M	+5.8%
Gross Profit	-$120,000	$1M	-109.5%
Operating Income	-$6M	-$11M	+41.9%
Net Income	-$9M	-$12M	+21.9%